Haibo Biotechnology Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 3

Haibo Biotechnology General Information

Description

Developer of near-infrared tumor imaging drugs designed to achieve precision targeting. The company specializes in the innovation of near-infrared, oxygen-deficient targeting contrast agents, notably NC527-X, providing the medical community with advanced solutions for precise tumor imaging and has multiple pipelines laid for solid tumors.

Contact Information

Formerly Known As
Ningbo Haibo Biotechnology Co., Ltd.
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • No. 1200, Xinghai North Road, Taoyuan Street
  • Ninghai County
  • Ningbo, Zhejiang 315600
  • China
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • No. 1200, Xinghai North Road, Taoyuan Street
  • Ninghai County
  • Ningbo, Zhejiang 315600
  • China

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Haibo Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 30-Oct-2023 Completed Generating Revenue
1. Seed Round 13-Jan-2022 Completed Startup
To view Haibo Biotechnology’s complete valuation and funding history, request access »

Haibo Biotechnology Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Puhua Capital Venture Capital Minority
NHH Ventures Corporate Venture Capital Minority
Sherpa Healthcare Partners Growth/Expansion Minority
To view Haibo Biotechnology’s complete investors history, request access »

Ready to get started?

Request a free trial

Haibo Biotechnology FAQs

  • When was Haibo Biotechnology founded?

    Haibo Biotechnology was founded in 2021.

  • Where is Haibo Biotechnology headquartered?

    Haibo Biotechnology is headquartered in Ningbo, China.

  • What industry is Haibo Biotechnology in?

    Haibo Biotechnology’s primary industry is Drug Discovery.

  • Is Haibo Biotechnology a private or public company?

    Haibo Biotechnology is a Private company.

  • What is Haibo Biotechnology’s current revenue?

    The current revenue for Haibo Biotechnology is .

  • Who are Haibo Biotechnology’s investors?

    Puhua Capital, NHH Ventures, and Sherpa Healthcare Partners have invested in Haibo Biotechnology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process